{"id":"https://openalex.org/W4403569474","doi":"https://doi.org/10.1016/j.htct.2024.09.490","title":"EVALUATING TREATMENT TIMELINES AND SURVIVAL OUTCOMES FOR PRIMARY CNS LYMPHOMA: A CROSS-SECTIONAL EVALUATION","display_name":"EVALUATING TREATMENT TIMELINES AND SURVIVAL OUTCOMES FOR PRIMARY CNS LYMPHOMA: A CROSS-SECTIONAL EVALUATION","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403569474","doi":"https://doi.org/10.1016/j.htct.2024.09.490"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2024.09.490","doi":"https://doi.org/10.1016/j.htct.2024.09.490","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.490","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2024.09.490","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101751654","display_name":"ACC Farias","orcid":"https://orcid.org/0009-0005-0127-5457","observed_orcids":["https://orcid.org/0009-0005-0127-5457"]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"ACC Farias","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063217321","display_name":"FET Filho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"FET Filho","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112090389","display_name":"IL Pontes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102939073","display_name":"Universidade Estadual do Cear\u00e1","ror":"https://ror.org/00sec1m50","country_code":"BR","type":"education","lineage":["https://openalex.org/I102939073"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"IL Pontes","raw_affiliation_strings":["Universidade Estadual do Cear\u00e1 (UECE), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Estadual do Cear\u00e1 (UECE), Fortaleza, Brazil","institution_ids":["https://openalex.org/I102939073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102569016","display_name":"LA Gurgel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"LA Gurgel","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007374339","display_name":"FAC Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"FAC Silva","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060698608","display_name":"DS Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"DS Oliveira","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074319252","display_name":"RM Ribeiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"RM Ribeiro","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]},{"author_position":"last","author":{"id":null,"display_name":"RS Andrade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165349","display_name":"Hospital Geral de Fortaleza","ror":"https://ror.org/05megpp22","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210165349"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"RS Andrade","raw_affiliation_strings":["Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil","institution_ids":["https://openalex.org/I4210165349"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24820974,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":null,"first_page":"S292","last_page":"S292"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12369","display_name":"Pneumocystis jirovecii pneumonia detection and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-central-nervous-system-lymphoma","display_name":"primary central nervous system lymphoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/treatment-initiation-delay","display_name":"delayed treatment initiation","score":0.48399999737739563},{"id":"https://openalex.org/keywords/time-to-hospital-arrival","display_name":"time to hospital arrival","score":0.7870000004768372},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8569999933242798},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.9129999876022339},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/delayed-diagnosis","display_name":"delayed diagnosis","score":0.5400000214576721},{"id":"https://openalex.org/keywords/referral-process","display_name":"referral process","score":0.6069999933242798},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.6209999918937683},{"id":"https://openalex.org/keywords/fortaleza-brazil","display_name":"Fortaleza","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9208531379699707},{"id":"https://openalex.org/C4438859","wikidata":"https://www.wikidata.org/wiki/Q186117","display_name":"Timeline","level":2,"score":0.7304744720458984},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.6665077805519104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4005810618400574},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.11237561702728271},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09454154968261719},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2024.09.490","doi":"https://doi.org/10.1016/j.htct.2024.09.490","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.490","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7acd60d7b40f4be79ba82abd12bccbff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7acd60d7b40f4be79ba82abd12bccbff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S292- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2024.09.490","doi":"https://doi.org/10.1016/j.htct.2024.09.490","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.490","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414800178","https://openalex.org/W4416109799","https://openalex.org/W1797036159","https://openalex.org/W2361398537","https://openalex.org/W3161883252","https://openalex.org/W2362597308","https://openalex.org/W2979433982","https://openalex.org/W2389692261","https://openalex.org/W3189240338","https://openalex.org/W2392786018"],"abstract_inverted_index":{"This":[0,360],"study":[1,63,361],"assesses":[2],"clinical":[3],"outcomes":[4,37,275],"for":[5,244,260,318,363],"primary":[6,199],"central":[7],"nervous":[8],"system":[9],"lymphoma":[10,330,382],"(PCNSL)":[11],"patients,":[12],"particularly":[13],"focusing":[14],"on":[15,35,53],"the":[16,30,40,65,112,128,147,198,227,265,281,301,309,327,342,351,379],"timelines":[17,34,228,369],"from":[18,150,173,229],"diagnosis":[19,151,174,230,340],"to":[20,86,91,144,152,160,175,183,195,231,325,355,366,373],"hospital":[21,153,232],"arrival,":[22],"treatment":[23,44,176,200,235,269,310,323,353,368],"initiation,":[24,88],"and":[25,38,51,89,100,146,207,234,322,341,370,377],"overall":[26,344],"survival.":[27],"It":[28],"examines":[29],"impact":[31,273],"of":[32,42,68,203,216,222,252,280,290,297,329,339,350,381],"these":[33],"patient":[36,137,274,358,375],"evaluates":[39,75],"effectiveness":[41],"a":[43,61,132,241,286,294,337,348],"regimen":[45,201,354,371],"that":[46],"includes":[47],"high-dose":[48,204],"methotrexate,":[49,205],"cytarabine,":[50,206],"rituximab":[52],"survival":[54,123,187,288,345],"rates":[55],"in":[56,64,226,268,308],"first":[57,302],"line.":[58],"Conducted":[59],"as":[60,83],"cross-sectional":[62],"hematology":[66],"ward":[67],"Hospital":[69],"Geral":[70],"de":[71],"Fortaleza,":[72],"this":[73],"research":[74,365],"patients":[76,164,217,239,254,298],"diagnosed":[77],"with":[78,115,197,214,293],"PCNSL.":[79],"Clinical":[80],"parameters":[81],"such":[82],"age,":[84],"time":[85,90,149,172,188,289],"chemotherapy":[87],"death":[92],"are":[93,96,106],"collected.":[94],"Data":[95],"summarized":[97],"using":[98,108,127],"medians":[99],"interquartile":[101],"ranges":[102],"(IQR).":[103],"Group":[104],"comparisons":[105],"facilitated":[107],"non-parametric":[109],"tests,":[110],"specifically":[111],"Mann-Whitney":[113],"U-test,":[114],"p-values":[116],"<":[117],"0.05":[118],"considered":[119],"statistically":[120],"significant.":[121],"Overall":[122],"(OS)":[124],"is":[125,139,155,178,190,212,283],"assessed":[126],"Kaplan-Meier":[129],"method,":[130],"maintaining":[131],"95%":[133],"confidence":[134],"interval.":[135],"Median":[136],"age":[138],"45.5":[140],"years":[141],"(IQR:":[142,158,181,193],"39.8":[143],"52.0),":[145],"median":[148,171,186,287],"arrival":[154,233],"-7.00":[156],"days":[157,180],"-19.0":[159],"17.0),":[161],"suggesting":[162,305],"some":[163,253],"were":[165],"referred":[166],"before":[167],"formal":[168],"diagnosis.":[169,223],"The":[170,185,209,224,249,277,312,332],"initiation":[177,236,270],"36":[179],"31.0":[182],"55.0).":[184],"post-diagnosis":[189],"7.07":[191,291],"months":[192],"3.22":[194],"18.6),":[196],"consisting":[202],"rituximab.":[208],"2-year":[210],"OS":[211],"25%,":[213],"66.7%":[215],"dying":[218,299],"within":[219,300,336],"one":[220],"year":[221,303,338],"variability":[225],"among":[237],"PCNSL":[238],"highlights":[240],"critical":[242],"need":[243,317],"more":[245,319,383],"efficient":[246],"care":[247],"processes.":[248],"early":[250],"referral":[251,258],"indicates":[255],"an":[256,315],"urgent":[257,316],"protocol":[259],"highly":[261],"suspected":[262],"cases,":[263],"yet":[264],"substantial":[266],"range":[267],"times":[271],"could":[272],"significantly.":[276],"aggressive":[278],"nature":[279],"disease":[282],"underscored":[284],"by":[285],"months,":[292],"significant":[295,333],"percentage":[296],"post-diagnosis,":[304],"potential":[306],"inadequacies":[307],"protocol.":[311],"findings":[313],"suggest":[314],"streamlined":[320],"diagnostic":[321],"protocols":[324],"improve":[326],"efficacy":[328,372],"care.":[331],"mortality":[334],"rate":[335,346],"low":[343],"necessitate":[347],"re-evaluation":[349],"standard":[352],"better":[356],"meet":[357],"needs.":[359],"advocates":[362],"further":[364],"optimize":[367],"enhance":[374],"prognosis":[376],"combat":[378],"severity":[380],"effectively.":[384]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-10-20T00:00:00"}